Trial Profile
Efficacy and safety of Apixaban and low molecular weight heparin,enoxaparin in patients with venous thromboembolism following total knee arthroplasty
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2017
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Enoxaparin sodium
- Indications Venous thromboembolism
- Focus Therapeutic Use
- 06 Sep 2017 New trial record